Latest filing published 21 Jul 2014 for Pure Bioscience, INC., €19k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -33.3%Entry US$1.02 · Close at T+365 US$0.68
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David M. Theno: trading record in brief
David M. Theno discloses dealings in Pure Bioscience, Inc. to SEC (Form 4). Over a trading history stretching from 23 October 2013 to 18 July 2014, the count stands at 3 filings.
On the market, this insider has only ever bought: 2 purchases, €38k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant. Since January 2015: 1 purchase and no sales on the market.
The newest entry dates from 9 September 2015: an open-market purchase of €19k, in Pure Bioscience, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David M. Theno
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 shares@ US$0.85Common StockSEC:0001209191-14-048235:0Canonical exit: 16 Oct 2014 (T+90)
- 200,000 shares0Common StockSEC:0001209191-13-049428:0
2 of 2 declarations
